MedPath

TYGACIL

TYGACIL

Approved
DIN Number

02285401

Drug Class

Human

Market Date

Nov 30, 2006

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02285401
AIG Number0151666001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01AA12 TIGECYCLINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.24.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

TIGECYCLINEActive
Strength: 50 MG / VIAL
Monograph: TIGECYCLINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.